{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T23:06:56Z","timestamp":1777936016121,"version":"3.51.4"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T00:00:00Z","timestamp":1762819200000},"content-version":"vor","delay-in-days":10,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004737","name":"National Health Research Institutes","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004737","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008903","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008903","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003625","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Formosan Medical Association"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.jfma.2025.11.016","type":"journal-article","created":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T20:39:13Z","timestamp":1764016753000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["2025 Taiwan consensus recommendations for primary care of chronic kidney disease"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4923-3342","authenticated-orcid":false,"given":"Yi-Chun","family":"Tsai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pei-Yu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tai-Shuan","family":"Lai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chih-Chien","family":"Sung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6840-5440","authenticated-orcid":false,"given":"Yi-Wen","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shang-Jyh","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yung-Ho","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mai-Szu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chung-Liang","family":"Shih","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.jfma.2025.11.016_bib1","doi-asserted-by":"crossref","DOI":"10.1111\/nep.70055","article-title":"Projection of the prevalence and economic burden of chronic kidney disease in Taiwan from 2022 to 2027 (Inside CKD): a microsimulation study","volume":"30","author":"Wu","year":"2025","journal-title":"Nephrology"},{"issue":"1 Suppl","key":"10.1016\/j.jfma.2025.11.016_bib2","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.jfma.2021.12.016","article-title":"Achievements and challenges in chronic kidney disease care in Taiwan","volume":"121","author":"Hsu","year":"2022","journal-title":"J Formos Med Assoc"},{"key":"10.1016\/j.jfma.2025.11.016_bib3","series-title":"National health insurance annual statistics","year":"2023"},{"issue":"1 Suppl","key":"10.1016\/j.jfma.2025.11.016_bib4","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1016\/j.jfma.2021.12.010","article-title":"Healthcare utilization and expenditure among individuals with end-stage kidney disease in Taiwan","volume":"121","author":"Lee","year":"2022","journal-title":"J Formos Med Assoc"},{"key":"10.1016\/j.jfma.2025.11.016_bib5","series-title":"National health research institutes and Taiwan society of nephrology","article-title":"2024 Taiwan annual report on kidney disease","author":"Hsu","year":"2024"},{"issue":"8","key":"10.1016\/j.jfma.2025.11.016_bib6","first-page":"1307","article-title":"Effect of a pay-for-performance program on renal outcomes among patients with early-stage chronic kidney disease in Taiwan","volume":"11","author":"Lin","year":"2022","journal-title":"Int J Health Pol Manag"},{"issue":"1 Suppl","key":"10.1016\/j.jfma.2025.11.016_bib7","doi-asserted-by":"crossref","first-page":"S64","DOI":"10.1016\/j.jfma.2021.12.008","article-title":"Multidisciplinary care program in pre-end-stage kidney disease from 2010 to 2018 in Taiwan","volume":"121","author":"Lin","year":"2022","journal-title":"J Formos Med Assoc"},{"issue":"12","key":"10.1016\/j.jfma.2025.11.016_bib9","first-page":"3049","article-title":"Barriers to implementing the kidney disease outcomes quality initiative end-stage kidney disease life plan guideline","volume":"38","author":"Keller","year":"2023","journal-title":"J Gen Intern Med"},{"issue":"1","key":"10.1016\/j.jfma.2025.11.016_bib10","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1186\/s12875-024-02589-w","article-title":"Guidelines or mindlines? \u2013 implementing a new CKD guideline in German primary care","volume":"25","author":"Laker","year":"2024","journal-title":"BMC Prim Care"},{"issue":"3","key":"10.1016\/j.jfma.2025.11.016_bib11","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.kint.2023.12.003","article-title":"Mind the gap in kidney care: translating what we know into what we do","volume":"105","author":"Luyckx","year":"2024","journal-title":"Kidney Int"},{"issue":"3","key":"10.1016\/j.jfma.2025.11.016_bib12","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1093\/ndt\/gfac283","article-title":"Overcoming barriers to implementing new guideline-directed therapies for chronic kidney disease","volume":"38","author":"Nee","year":"2023","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"10.1016\/j.jfma.2025.11.016_bib13","doi-asserted-by":"crossref","first-page":"624","DOI":"10.3122\/jabfm.2015.05.150070","article-title":"Chronic kidney disease guideline implementation in primary care: a qualitative report from the TRANSLATE CKD study","volume":"28","author":"Vest","year":"2015","journal-title":"J Am Board Fam Med"},{"issue":"5 Suppl","key":"10.1016\/j.jfma.2025.11.016_bib14","first-page":"S1","article-title":"KDIGO 2022 clinical practice guideline for diabetes management in chronic kidney disease","volume":"102","year":"2022","journal-title":"Kidney Int"},{"issue":"3","key":"10.1016\/j.jfma.2025.11.016_bib15","first-page":"225","article-title":"2022 guidelines of the Taiwan society of cardiology and the Taiwan hypertension society for the management of hypertension","volume":"38","author":"Wang","year":"2022","journal-title":"Acta Cardiol Sin"},{"issue":"1","key":"10.1016\/j.jfma.2025.11.016_bib16","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.kint.2018.08.036","article-title":"Long-term risk of adverse outcomes after acute kidney injury: a systematic review and meta-analysis of cohort studies using consensus definitions of exposure","volume":"95","author":"See","year":"2019","journal-title":"Kidney Int"},{"issue":"10","key":"10.1016\/j.jfma.2025.11.016_bib17","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/S2213-8587(17)30221-8","article-title":"Development and validation of risk equations for complications of type 2 diabetes (RECODe) using individual participant data from randomised trials","volume":"5","author":"Basu","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"21","key":"10.1016\/j.jfma.2025.11.016_bib18","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1001\/jama.2019.17379","article-title":"Development of risk prediction equations for incident chronic kidney disease","volume":"322","author":"Nelson","year":"2019","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.jfma.2025.11.016_bib19","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1053\/j.ajkd.2017.09.013","article-title":"Validity of a risk prediction equation for CKD after 10 years of Follow-up in a Japanese population: the Ibaraki prefectural health study","volume":"71","author":"Umesawa","year":"2018","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1016\/j.jfma.2025.11.016_bib20","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1186\/s12882-017-0653-z","article-title":"Risk scores to predict decreased glomerular filtration rate at 10 years in an Asian general population","volume":"18","author":"Saranburut","year":"2017","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.jfma.2025.11.016_bib21","series-title":"Taiwan clinical practice guideline for chronic kidney disease, 2025 update, version 0831","year":"2025"},{"issue":"7","key":"10.1016\/j.jfma.2025.11.016_bib22","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1093\/ndt\/gfz062","article-title":"Nonsteroidal anti-inflammatory drug use and risk of acute kidney injury and hyperkalemia in older adults: a population-based study","volume":"34","author":"Nash","year":"2019","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"10.1016\/j.jfma.2025.11.016_bib23","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.kint.2025.04.005","article-title":"Preventing chronic kidney disease and maintaining kidney health: conclusions from a kidney disease: improving global outcomes (KDIGO) controversies conference","volume":"108","author":"Ortiz","year":"2025","journal-title":"Kidney Int"},{"issue":"4 Suppl","key":"10.1016\/j.jfma.2025.11.016_bib24","first-page":"S117","article-title":"KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"105","year":"2024","journal-title":"Kidney Int"},{"key":"10.1016\/j.jfma.2025.11.016_bib25","series-title":"Early chronic kidney disease care handbook","year":"2022"},{"issue":"6","key":"10.1016\/j.jfma.2025.11.016_bib26","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1681\/ASN.2020081155","article-title":"Low health literacy is associated with the onset of CKD during the life course","volume":"32","author":"Gurgel do Amaral","year":"2021","journal-title":"J Am Soc Nephrol"},{"issue":"8","key":"10.1016\/j.jfma.2025.11.016_bib27","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1161\/CIRCULATIONAHA.111.060681","article-title":"Healthy lifestyle through young adulthood and the presence of low cardiovascular disease risk profile in middle age: the coronary artery risk Development in (Young) adults (CARDIA) study","volume":"125","author":"Liu","year":"2012","journal-title":"Circulation"},{"issue":"20","key":"10.1016\/j.jfma.2025.11.016_bib28","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1161\/CIR.0000000000001184","article-title":"Cardiovascular-kidney-metabolic health: a presidential advisory from the American heart association","volume":"148","author":"Ndumele","year":"2023","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.jfma.2025.11.016_bib29","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1161\/CIR.0000000000001078","article-title":"Life's essential 8: updating and enhancing the American heart association's construct of cardiovascular health: a presidential advisory from the American heart association","volume":"146","author":"Lloyd-Jones","year":"2022","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.jfma.2025.11.016_bib30","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/S2213-8587(14)70156-1","article-title":"Effect of a long-term behavioural weight loss intervention on nephropathy in overweight or obese adults with type 2 diabetes: a secondary analysis of the look AHEAD randomised clinical trial","volume":"2","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"4","key":"10.1016\/j.jfma.2025.11.016_bib31","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1053\/j.ajkd.2017.12.016","article-title":"Social determinants of health: addressing unmet needs in nephrology","volume":"72","author":"Hall","year":"2018","journal-title":"Am J Kidney Dis"},{"issue":"11","key":"10.1016\/j.jfma.2025.11.016_bib32","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.45309","article-title":"Prevalence of cardiovascular-kidney-metabolic syndrome stages by social determinants of health","volume":"7","author":"Zhu","year":"2024","journal-title":"JAMA Netw Open"},{"issue":"1","key":"10.1016\/j.jfma.2025.11.016_bib35","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.amjmed.2014.07.042","article-title":"Multidisciplinary care program for advanced chronic kidney disease: reduces renal replacement and medical costs","volume":"128","author":"Chen","year":"2015","journal-title":"Am J Med"},{"issue":"14","key":"10.1016\/j.jfma.2025.11.016_bib36","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000003282","article-title":"Long-term and interactive effects of pay-for-performance interventions among diabetic nephropathy patients at the early chronic kidney disease stage","volume":"95","author":"Liao","year":"2016","journal-title":"Medicine (Baltim)"},{"issue":"4","key":"10.1016\/j.jfma.2025.11.016_bib37","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.kint.2023.10.016","article-title":"Executive summary of the KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease: known knowns and known unknowns","volume":"105","author":"Levin","year":"2024","journal-title":"Kidney Int"},{"issue":"13","key":"10.1016\/j.jfma.2025.11.016_bib38","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1001\/jama.2023.17002","article-title":"Estimated glomerular filtration rate, albuminuria, and adverse outcomes: an individual-participant data meta-analysis","volume":"330","author":"Grams","year":"2023","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.jfma.2025.11.016_bib39","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1093\/ndt\/gfw452","article-title":"Cigarette smoking and chronic kidney disease in the general population: a systematic review and meta-analysis of prospective cohort studies","volume":"32","author":"Xia","year":"2017","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"10.1016\/j.jfma.2025.11.016_bib40","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1053\/j.ajkd.2016.02.052","article-title":"Smoking and adverse outcomes in patients with CKD: the study of heart and renal protection (SHARP)","volume":"68","author":"Staplin","year":"2016","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"10.1016\/j.jfma.2025.11.016_bib41","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1038\/ki.2014.370","article-title":"Modifiable lifestyle and social factors affect chronic kidney disease in high-risk individuals with type 2 diabetes mellitus","volume":"87","author":"Dunkler","year":"2015","journal-title":"Kidney Int"},{"issue":"2","key":"10.1016\/j.jfma.2025.11.016_bib42","doi-asserted-by":"crossref","first-page":"272","DOI":"10.2215\/CJN.06190616","article-title":"Healthy dietary patterns and risk of mortality and ESRD in CKD: a meta-analysis of cohort studies","volume":"12","author":"Kelly","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.jfma.2025.11.016_bib43","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/sj.ki.5002586","article-title":"Association between obesity and kidney disease: a systematic review and meta-analysis","volume":"73","author":"Wang","year":"2008","journal-title":"Kidney Int"},{"key":"10.1016\/j.jfma.2025.11.016_bib44","series-title":"Chronic kidney disease: assessment and management","year":"2021"},{"issue":"2 Suppl 1","key":"10.1016\/j.jfma.2025.11.016_bib45","first-page":"S1","article-title":"K\/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification","volume":"39","year":"2002","journal-title":"Am J Kidney Dis"},{"issue":"10","key":"10.1016\/j.jfma.2025.11.016_bib46","first-page":"e212","volume":"82","author":"Jones","year":"2025","journal-title":"Hypertension"},{"key":"10.1016\/j.jfma.2025.11.016_bib47","series-title":"Taiwan clinical guideline for the care of diabetic kidney disease","year":"2024"},{"issue":"1 Suppl 1","key":"10.1016\/j.jfma.2025.11.016_bib48","first-page":"S128","article-title":"6. Glycemic goals and hypoglycemia: standards of care in Diabetes-2025","volume":"48","year":"2025","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.jfma.2025.11.016_bib49","first-page":"161","article-title":"Taiwan consensus on clinical pathway for lipid management","volume":"41","author":"Lee","year":"2025","journal-title":"Acta Cardiol Sin"},{"issue":"8","key":"10.1016\/j.jfma.2025.11.016_bib50","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1111\/jdi.14222","article-title":"Optimizing lipid control in Taiwanese diabetic patients: a collaborative consensus by the diabetes association of the Republic of China (Taiwan) and the Taiwanese association of diabetes educators","volume":"15","author":"Shen","year":"2024","journal-title":"J Diabetes Investig"},{"issue":"1 Suppl 1","key":"10.1016\/j.jfma.2025.11.016_bib51","first-page":"S181","article-title":"9. Pharmacologic approaches to glycemic treatment: standards of care in Diabetes-2025","volume":"48","year":"2025","journal-title":"Diabetes Care"},{"issue":"15","key":"10.1016\/j.jfma.2025.11.016_bib52","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1056\/NEJMoa2024816","article-title":"Dapagliflozin in patients with chronic kidney disease","volume":"383","author":"Heerspink","year":"2020","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.jfma.2025.11.016_bib53","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1056\/NEJMoa2204233","article-title":"Empagliflozin in patients with chronic kidney disease","volume":"388","author":"Herrington","year":"2023","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.jfma.2025.11.016_bib54","doi-asserted-by":"crossref","first-page":"771","DOI":"10.34067\/KID.0000000000000425","article-title":"SGLT2 inhibitors and kidney protection: mechanisms beyond tubuloglomerular feedback","volume":"5","author":"Upadhyay","year":"2024","journal-title":"Kidney360"},{"issue":"4","key":"10.1016\/j.jfma.2025.11.016_bib55","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1681\/ASN.2018080844","article-title":"Macula densa SGLT1-NOS1-Tubuloglomerular feedback pathway, a new mechanism for glomerular hyperfiltration during hyperglycemia","volume":"30","author":"Zhang","year":"2019","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"10.1016\/j.jfma.2025.11.016_bib56","doi-asserted-by":"crossref","first-page":"359","DOI":"10.3803\/EnM.2023.1764","article-title":"Intrarenal mechanisms of sodium-glucose Cotransporter-2 inhibitors on tubuloglomerular feedback and natriuresis","volume":"38","author":"Koh","year":"2023","journal-title":"Endocrinol Metab (Seoul)"},{"issue":"4","key":"10.1016\/j.jfma.2025.11.016_bib57","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1161\/CIRCULATIONAHA.123.064346","article-title":"Critical analysis of the effects of SGLT2 inhibitors on renal tubular sodium, water and chloride homeostasis and their role in influencing heart failure outcomes","volume":"148","author":"Packer","year":"2023","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.jfma.2025.11.016_bib58","doi-asserted-by":"crossref","first-page":"693","DOI":"10.7326\/M23-1874","article-title":"Sodium-glucose Cotransporter-2 inhibitors and the risk for dialysis and cardiovascular disease in patients with stage 5 chronic kidney disease","volume":"177","author":"Yen","year":"2024","journal-title":"Ann Intern Med"},{"issue":"23","key":"10.1016\/j.jfma.2025.11.016_bib59","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1056\/NEJMoa2025845","article-title":"Effect of finerenone on chronic kidney disease outcomes in type 2 diabetes","volume":"383","author":"Bakris","year":"2020","journal-title":"N Engl J Med"},{"issue":"24","key":"10.1016\/j.jfma.2025.11.016_bib60","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1056\/NEJMoa2110956","article-title":"Cardiovascular events with finerenone in kidney disease and type 2 diabetes","volume":"385","author":"Pitt","year":"2021","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.jfma.2025.11.016_bib61","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1056\/NEJMoa2403347","article-title":"Effects of semaglutide on chronic kidney disease in patients with type 2 diabetes","volume":"391","author":"Perkovic","year":"2024","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.jfma.2025.11.016_bib62","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1093\/eurheartj\/ehab777","article-title":"Finerenone and cardiovascular outcomes in patients with chronic kidney disease and type 2 diabetes: a pooled individual patient-level analysis (FIDELITY)","volume":"43","author":"Agarwal","year":"2022","journal-title":"Eur Heart J"},{"issue":"24","key":"10.1016\/j.jfma.2025.11.016_bib63","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1056\/NEJMoa2307563","article-title":"Semaglutide and cardiovascular outcomes in obesity without diabetes","volume":"389","author":"Lincoff","year":"2023","journal-title":"N Engl J Med"},{"issue":"13","key":"10.1016\/j.jfma.2025.11.016_bib64","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1001\/jama.2019.14745","article-title":"Chronic kidney disease diagnosis and management: a review","volume":"322","author":"Chen","year":"2019","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.jfma.2025.11.016_bib65","first-page":"CD007333","article-title":"Early referral to specialist nephrology services for preventing the progression to end-stage kidney disease","author":"Smart","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1016\/j.jfma.2025.11.016_bib66","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ekir.2016.09.062","article-title":"Timely referral to outpatient nephrology care slows progression and reduces treatment costs of chronic kidney diseases","volume":"2","author":"Lonnemann","year":"2017","journal-title":"Kidney Int Rep"},{"issue":"4","key":"10.1016\/j.jfma.2025.11.016_bib67","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1046\/j.1523-1755.2003.00868.x","article-title":"Proteinuria and the risk of developing end-stage renal disease","volume":"63","author":"Iseki","year":"2003","journal-title":"Kidney Int"},{"issue":"2","key":"10.1016\/j.jfma.2025.11.016_bib68","first-page":"85","article-title":"Acute kidney injury: definition, pathophysiology and clinical phenotypes","volume":"37","author":"Makris","year":"2016","journal-title":"Clin Biochem Rev"},{"issue":"6","key":"10.1016\/j.jfma.2025.11.016_bib69","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1093\/ckj\/sfy032","article-title":"Renal function at the time of nephrology referral but not dialysis initiation as a risk for death in patients with diabetes mellitus","volume":"11","author":"Pinier","year":"2018","journal-title":"Clin Kidney J"}],"container-title":["Journal of the Formosan Medical Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664625006230?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664625006230?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T10:06:41Z","timestamp":1766138801000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0929664625006230"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":66,"alternative-id":["S0929664625006230"],"URL":"https:\/\/doi.org\/10.1016\/j.jfma.2025.11.016","relation":{},"ISSN":["0929-6646"],"issn-type":[{"value":"0929-6646","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"2025 Taiwan consensus recommendations for primary care of chronic kidney disease","name":"articletitle","label":"Article Title"},{"value":"Journal of the Formosan Medical Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jfma.2025.11.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2025, Formosan Medical Association. Published by Elsevier Taiwan LLC. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}